Traws Pharma (TRAW) Enterprise Value (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Enterprise Value of -$3.1 million for Q1 2026, up 80.34% year-over-year from -$1.7 million in Q1 2025, and up 17.98% quarter-over-quarter from -$3.8 million in Q4 2025.
Traws Pharma (TRAW) Enterprise Value (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Enterprise Value for 15 consecutive years, with -$3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 80.34% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at -$3.1 million (up 80.34% YoY), while the FY2025 annual figure was -$3.8 million, up 82.1% from the prior year.
- Enterprise Value grew to -$3.1 million in Q1 2026 per TRAW's latest filing, from -$3.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.1 million in Q1 2026 and bottomed at -$50.8 million in Q1 2022.
- Historically, Enterprise Value has averaged -$23.0 million across 5 years, with a median of -$20.8 million in 2023.
- On a YoY basis, Enterprise Value climbed as much as 82.1% in 2025 and fell as far as 18.67% in 2025.
- Traws Pharma's Enterprise Value stood at -$38.8 million in 2022, then surged by 46.28% to -$20.8 million in 2023, then decreased by 2.48% to -$21.3 million in 2024, then jumped by 82.1% to -$3.8 million in 2025, then gained by 17.98% to -$3.1 million in 2026.
- Business Quant data shows TRAW's Enterprise Value at -$3.1 million in Q1 2026, -$3.8 million in Q4 2025, and -$6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | -5.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.13 Mn |
| Dec 31, 2025 | -3.82 Mn |
| Sep 30, 2025 | -6.42 Mn |
| Jun 30, 2025 | -13.08 Mn |
| Mar 31, 2025 | -15.94 Mn |
| Dec 31, 2024 | -21.34 Mn |
| Sep 30, 2024 | -5.41 Mn |
| Jun 30, 2024 | -16.89 Mn |
| Mar 31, 2024 | -16.39 Mn |
| Dec 31, 2023 | -20.82 Mn |
| Sep 30, 2023 | -25.24 Mn |
| Jun 30, 2023 | -29.73 Mn |
| Mar 31, 2023 | -34.22 Mn |
| Dec 31, 2022 | -38.76 Mn |
| Sep 30, 2022 | -42.61 Mn |
| Jun 30, 2022 | -46.53 Mn |
| Mar 31, 2022 | -50.77 Mn |
| Dec 31, 2021 | -55.07 Mn |
| Sep 30, 2021 | -59.38 Mn |
| Jun 30, 2021 | -43.71 Mn |